DekaBank Deutsche Girozentrale’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
DekaBank Deutsche Girozentrale's AMED Position: Q1 2022 in Review
DekaBank Deutsche Girozentrale sold out of Amedisys (AMED) in Q1 2022, closing a stake of 4,579 shares — an estimated $743K sold.
DekaBank Deutsche Girozentrale first reported a position in AMED in Q1 2018 and held it in 16 quarters. The position peaked at $4.61M in Q2 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.
- DekaBank Deutsche Girozentrale reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 4,579 Amedisys shares in Q1 2022, an estimated $743K.
- DekaBank Deutsche Girozentrale first reported a position in Amedisys in Q1 2018 and held it in 16 quarters.
- DekaBank Deutsche Girozentrale's Amedisys position peaked at $4.61M in Q2 2021.
- 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2022, filed 28 Apr 2022.